FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders. Compounded products are not evaluated by the FDA for safety and effectiveness. They’re also not regulated like approved drugs,Continue Reading